1998
DOI: 10.1002/(sici)1520-6394(1998)8:1+<18::aid-da4>3.0.co;2-p
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacologic treatment of depression in women: PMS, pregnancy, and the postpartum period

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 47 publications
0
2
0
Order By: Relevance
“…This difference may be due to the assessment tools, geographic, and cut-off point differences. Prior studies that have noted the importance of recurrent PPD in women with a prior episode of postpartum affective psychosis may be at risk for recurrence postpartum 50–70% [56]. …”
Section: Discussionmentioning
confidence: 99%
“…This difference may be due to the assessment tools, geographic, and cut-off point differences. Prior studies that have noted the importance of recurrent PPD in women with a prior episode of postpartum affective psychosis may be at risk for recurrence postpartum 50–70% [56]. …”
Section: Discussionmentioning
confidence: 99%
“…There is considerable debate around the safety of psychotropic medication during and after pregnancy [ 9 , 10 ]. Despite many studies on the safety and efficacy of pharmacological interventions for treating PPD [ 9 , 10 ], concerns remain about the potential adverse effects of certain types of pharmacological therapy on breastfed newborns and babies [ 10 ].…”
Section: Introductionmentioning
confidence: 99%